ESC Premium Access

Andexanet alfa reduces betrixaban-induced blood loss in a rabbit liver laceration model of acute bleeding.

Topic: Primary cardiovascular prevention: interventions and outcomes

Congress Presentation

About the speaker

Doctor Pamela Conley

Portola Pharmaceuticals Inc., South San Francisco (United States of America)
0 follower

27 more presentations in this session

Major adverse cardiovascular events (MACE) are reduced in testosterone-treated vs. untreated hypogonadal men: real-life evidence from a controlled registry study

Speaker: Professor F. Saad (Berlin, DE)


Enhanced cardiovascular susceptibility to air pollution: A 4 years echocardiographic study of pulmonary circulation.

Speaker: Professor J. Argacha (Brussels, BE)


Systemic inflammatory response in chronic venous disorders and their clinical relevance in the general population.

Speaker: Doctor N. Arnold (Mainz, DE)


The hemoglobin A1C and creatinine are associated with coronary calcium score for female but not male in a general low risk population

Speaker: Doctor J. Wu (Toufen, TW)


ABCA1 gene polymorphism InsG319 prevents the development of impaired glucose tolerance in young and middle-aged women

Speaker: Professor S. Boldueva (Saint Petersburg, RU)


Access the full session

Poster session 7 - Prevention general

Speakers: Doctor P. Conley, Professor F. Saad, Professor J. Argacha, Doctor N. Arnold, Doctor J. Wu...

About the event


ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by